DEFA14A: CareCloud Nears Approval for Series A Preferred Stock Proposal with 99% of Required Votes Secured

CareCloud announces it has secured approximately 99% of the required votes for the amendment to its Series A Preferred Stock, aiming to provide similar change of control protections and dividend mirroring to its Series B Preferred Stock.

Summary

• CareCloud has obtained approximately 99% of the minimum required votes to approve the amendment to its Series A Preferred Stock.
• As of September 10, 2024, the company has supportive proxy indications from more than 2.97 million shares, approaching the 3.02 million share threshold.
• The amendment aims to provide Series A Preferred Stock holders with similar change of control protections as Series B Preferred Stock holders.
• The dividend of Series A Preferred Stock would mirror that of the Series B Preferred Stock.
• CareCloud would have the right to exchange Series A Preferred Stock for common stock at $25 per share, plus accrued and unpaid dividends.
• The Special Meeting is scheduled for September 11, 2024, but may be adjourned to allow for continued vote solicitation.
• The company cannot predict future proxy or voting results.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the high level of support for the proposal, but tempered by the uncertainty of future voting results and the risks associated with forward-looking statements.

Positives

• High level of support for the Series A Preferred Stock proposal indicates shareholder confidence.
• Alignment of Series A and Series B Preferred Stock terms could simplify the company's capital structure.
• The right to exchange Series A Preferred Stock for common stock provides CareCloud with potential financial flexibility.

Negatives

• The company cannot predict future proxy or voting results, which could be less favorable.
• Unvoted shares will be counted as 'no' votes for the Preferred Stock Proposal.

Risks

• Failure to secure the remaining votes could prevent the approval of the amendment.
• The company's forward-looking statements are subject to various risks and uncertainties, including those related to growth management, customer retention, and regulatory changes.
• The company's ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled Risk Factors in the Companys filings with the Securities and Exchange Commission.

Future Outlook

The company is optimistic about the potential approval of the Series A Preferred Stock proposal but acknowledges uncertainty in future proxy or voting results. They do not have an ongoing obligation to update shareholders regarding future proxy or vote trends, even if they are materially different from those experienced to date.

Management Comments

• CareCloud believes it is quickly approaching the required 3.02 million share threshold for approval of the Series A Preferred Stock proposal.

Industry Context

This announcement reflects CareCloud's efforts to optimize its capital structure and align the terms of its preferred stock offerings. This is a common practice among publicly traded companies to enhance investor appeal and streamline operations.

Comparison to Industry Standards

• It is difficult to compare CareCloud's specific situation to industry standards without knowing the exact terms of the Series A and Series B preferred stock, but aligning preferred stock terms is a common practice.
• Many companies, such as Teva Pharmaceutical Industries Limited, have undertaken similar efforts to simplify their capital structure and improve shareholder value.

Stakeholder Impact

• Shareholders of Series A Preferred Stock would benefit from similar change of control protections and dividend mirroring as Series B Preferred Stock holders if the proposal is approved.
• The company could benefit from increased financial flexibility if it gains the right to exchange Series A Preferred Stock for common stock.

Next Steps

• Continued solicitation of proxy votes from Series A Preferred Stock shareholders.
• Holding the Special Meeting of Series A Preferred Stock shareholders on September 11, 2024, or a later adjourned date.
• Implementation of the amendment to the Certificate of Designations, Preferences and Rights of Series A Preferred Stock if approved.

Key Dates

Keywords

CareCloud, Series A Preferred Stock, Proxy Vote, Amendment, Shareholders, Healthcare Technology